Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-05 Paulson Richard A. Director Grant or award · Nonstatutory Stock Option (right to buy) +50,000 50,000
2020-03-02 Primiano Christopher Brett EVP, CBO, GC & Secretary Exercise or conversion +26,500 $10.39 $275K 36,867
2020-03-02 Primiano Christopher Brett EVP, CBO, GC & Secretary Sale −7,500 $23.50 $176K 29,367
2020-03-02 Primiano Christopher Brett EVP, CBO, GC & Secretary Sale −10,000 $28.00 $280K 19,367
2020-03-02 Primiano Christopher Brett EVP, CBO, GC & Secretary Sale −9,000 $24.00 $216K 10,367
2020-03-02 Primiano Christopher Brett EVP, CBO, GC & Secretary Exercise or conversion · Stock Option (right to buy) −26,500 76,500
2020-03-02 Mirza Mansoor Raza Director Exercise or conversion +5,000 $8.06 $40K 5,000
2020-03-02 Mirza Mansoor Raza Director Sale −5,000 $23.50 $118K 0
2020-03-02 Mirza Mansoor Raza Director Exercise or conversion · Stock Option (right to buy) −5,000 0
2020-02-19 Shah Jatin EVP, Chief Medical Officer Sale −1,375 $16.48 $23K 40,759
2020-02-19 Frenkel Ran Chief Dev Operations Officer Sale −2,975 $16.48 $49K 36,066
2020-02-19 Primiano Christopher Brett EVP, CBO, GC & Secretary Sale −2,961 $16.48 $49K 10,367
2020-02-19 Shacham Sharon President & CSO Sale −8,817 $16.48 $145K 756,489
2020-02-19 Shacham Sharon President & CSO Sale −8,817 $16.48 $145K 555,122
2020-02-19 Kauffman Michael Chief Executive Officer Sale −8,817 $16.48 $145K 555,122
2020-02-19 Kauffman Michael Chief Executive Officer Sale −8,817 $16.48 $145K 756,489
2020-02-15 Shah Jatin EVP, Chief Medical Officer Exercise or conversion +4,850 42,134
2020-02-15 Shah Jatin EVP, Chief Medical Officer Exercise or conversion · Restricted Stock Units −4,850 14,550
2020-02-15 Frenkel Ran Chief Dev Operations Officer Exercise or conversion +9,675 39,041
2020-02-15 Frenkel Ran Chief Dev Operations Officer Exercise or conversion · Restricted Stock Units −9,675 29,025

Page 28 of 29 · 570 trades